Bicycle Therapeutics (BCYC) Free Cash Flow: 2018-2025
Historic Free Cash Flow for Bicycle Therapeutics (BCYC) over the last 7 years, with Sep 2025 value amounting to -$71.8 million.
- Bicycle Therapeutics' Free Cash Flow fell 78.43% to -$71.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$241.9 million, marking a year-over-year decrease of 18.83%. This contributed to the annual value of -$166.0 million for FY2024, which is 161.12% down from last year.
- Per Bicycle Therapeutics' latest filing, its Free Cash Flow stood at -$71.8 million for Q3 2025, which was up 1.96% from -$73.3 million recorded in Q2 2025.
- In the past 5 years, Bicycle Therapeutics' Free Cash Flow ranged from a high of $33.8 million in Q2 2023 and a low of -$87.0 million during Q1 2025.
- Over the past 3 years, Bicycle Therapeutics' median Free Cash Flow value was -$47.3 million (recorded in 2023), while the average stood at -$42.0 million.
- In the last 5 years, Bicycle Therapeutics' Free Cash Flow skyrocketed by 313.78% in 2021 and then tumbled by 2,537.00% in 2024.
- Over the past 5 years, Bicycle Therapeutics' Free Cash Flow (Quarterly) stood at -$11.5 million in 2021, then crashed by 176.10% to -$31.8 million in 2022, then crashed by 49.07% to -$47.3 million in 2023, then skyrocketed by 79.37% to -$9.8 million in 2024, then plummeted by 78.43% to -$71.8 million in 2025.
- Its Free Cash Flow was -$71.8 million in Q3 2025, compared to -$73.3 million in Q2 2025 and -$87.0 million in Q1 2025.